POU6F2 Polyclonal Antibody, PE-Cy7 Conjugated
Cat# bs-6084R-PE-Cy7
Size : 100uL
Brand : Bioss
Applications
Predicted Reactivity
| Overview | |
| Catalog # | bs-6084R-PE-Cy7 |
| Product Name | POU6F2 Polyclonal Antibody, PE-Cy7 Conjugated |
| Applications | WB |
| Predicted Reactivity | Human, Mouse, Rat, Dog, Sheep, Pig, Horse, Chicken, Rabbit |
| Specifications | |
| Conjugation | PE-Cy7 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human POU6F2 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 11281 |
| Subcellular location | Nucleus |
| Synonyms | POU class 6 homeobox 2; POU domain class 6 transcription factor 2; Retina derived POU domain factor 1; RPF 1; RPF1; Wilms tumor suppressor locus; WT 5; WT5; WTSL; PO6F2_HUMAN. |
| Background | This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. |
| Application Dilution | |
| WB | 1:300-5000 |

